ZERO To ONEAdvancement of Radioligand Therapy
ZERO To ONEAdvancement of Radioligand Therapy
SCROLL
- Head Office
- Gwanggyo R&D Center
- USA Office
(34141) BVC #121, 125 Gwahak-ro, Yuseong-
gu, Daejeon, Repulic of Korea
- TEL + 82-70-8723-0566
- FAX + 82-70-7966-0567
info@ztibio.com
(16864) 6F, 20 Poeun-daero 59beon-gil, Suji-gu, Yongin-si,Gyeonggi-do, Republic of Korea
- TEL + 82-31-213-0566
- FAX + 82-31-213-0567
info@ztibio.com
Standard Radiopharmaceuticals for Theragnostic Oncology
Next GenerationStandardization of Radiopharmaceutical Development
TERACARRIERTM
Next GenerationStandardization of Radiopharmaceutical Development TERACARRIERTM
DETAIL VIEW
